APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal Stromal Tumor (GIST) Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis and Forecast 2026-2032

22 December 2025207 pages

Choose your research edition.

Industry ResearchGastrointestinal Stromal Tumor (GIST) Drug Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal Stromal Tumor (GIST) Drug Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Gastrointestinal Stromal Tumor (GIST) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal Stromal Tumor (GIST) Drug Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Gastrointestinal Stromal Tumor (GIST) Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gastrointestinal Stromal Tumor (GIST) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gastrointestinal Stromal Tumor (GIST) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gastrointestinal Stromal Tumor (GIST) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gastrointestinal Stromal Tumor (GIST) Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug include Novartis AG, Jiangsu Hengrui Medicine Co., Ltd., Omeros Corporation, Nerviano Medical Sciences S.r.l., Natco Pharma Limited, Kolltan Pharmaceuticals, Inc., Immunicum AB, Horizon Pharma Plc and F. Hoffmann-La Roche Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gastrointestinal Stromal Tumor (GIST) Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gastrointestinal Stromal Tumor (GIST) Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Gastrointestinal Stromal Tumor (GIST) Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gastrointestinal Stromal Tumor (GIST) Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gastrointestinal Stromal Tumor (GIST) Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gastrointestinal Stromal Tumor (GIST) Drug sales, projected growth trends, production technology, application and end-user industry.

Gastrointestinal Stromal Tumor (GIST) Drug Segment by Company

Novartis AG

Jiangsu Hengrui Medicine Co., Ltd.

Omeros Corporation

Nerviano Medical Sciences S.r.l.

Natco Pharma Limited

Kolltan Pharmaceuticals, Inc.

Immunicum AB

Horizon Pharma Plc

F. Hoffmann-La Roche Ltd.

Deciphera Pharmaceuticals, LLC

Chipscreen Biosciences Ltd

Calithera Biosciences, Inc.

Boston Biomedical, Inc.

Blueprint Medicines Corporation

Astex Pharmaceuticals, Inc.

Array BioPharma Inc.

Arog Pharmaceuticals, Inc.

Ariad Pharmaceuticals, Inc.

Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type

Amcasertib

Anagrelide hydrochloride CR

APG-1351

Binimetinib

Others

Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application

Clinic

Hospital

Others

Gastrointestinal Stromal Tumor (GIST) Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal Stromal Tumor (GIST) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal Stromal Tumor (GIST) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal Stromal Tumor (GIST) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gastrointestinal Stromal Tumor (GIST) Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gastrointestinal Stromal Tumor (GIST) Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Stromal Tumor (GIST) Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Amcasertib Major Manufacturers Table 3. Anagrelide hydrochloride CR Major Manufacturers Table 4. APG-1351 Major Manufacturers Table 5. Binimetinib Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Clinic Major Manufacturers Table 9. Hospital Major Manufacturers Table 10. Others Major Manufacturers Table 11. Gastrointestinal Stromal Tumor (GIST) Drug Industry Trends Table 12. Gastrointestinal Stromal Tumor (GIST) Drug Industry Drivers Table 13. Gastrointestinal Stromal Tumor (GIST) Drug Industry Opportunities and Challenges Table 14. Gastrointestinal Stromal Tumor (GIST) Drug Industry Restraints Table 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2021-2026) Table 19. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2027-2032) Table 20. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2021-2026) & (k units) Table 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2027-2032) & (k units) Table 23. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2021-2026) Table 24. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2027-2032) Table 25. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturers (2021-2026) Table 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 30. Global Gastrointestinal Stromal Tumor (GIST) Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Gastrointestinal Stromal Tumor (GIST) Drug Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers, Product Type & Application Table 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Gastrointestinal Stromal Tumor (GIST) Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2021-2026) Table 40. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2027-2032) Table 41. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (k units) Table 43. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2027-2032) & (k units) Table 44. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2021-2026) Table 45. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2027-2032) Table 46. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2021-2026) & (US$/unit) Table 47. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2027-2032) & (US$/unit) Table 48. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2021-2026) Table 52. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2027-2032) Table 53. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (k units) Table 55. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2027-2032) & (k units) Table 56. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2021-2026) Table 57. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2027-2032) Table 58. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2021-2026) & (US$/unit) Table 59. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2027-2032) & (US$/unit) Table 60. Novartis AG Company Information Table 61. Novartis AG Business Overview Table 62. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 63. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 64. Novartis AG Recent Development Table 65. Jiangsu Hengrui Medicine Co., Ltd. Company Information Table 66. Jiangsu Hengrui Medicine Co., Ltd. Business Overview Table 67. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 69. Jiangsu Hengrui Medicine Co., Ltd. Recent Development Table 70. Omeros Corporation Company Information Table 71. Omeros Corporation Business Overview Table 72. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 74. Omeros Corporation Recent Development Table 75. Nerviano Medical Sciences S.r.l. Company Information Table 76. Nerviano Medical Sciences S.r.l. Business Overview Table 77. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 79. Nerviano Medical Sciences S.r.l. Recent Development Table 80. Natco Pharma Limited Company Information Table 81. Natco Pharma Limited Business Overview Table 82. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 84. Natco Pharma Limited Recent Development Table 85. Kolltan Pharmaceuticals, Inc. Company Information Table 86. Kolltan Pharmaceuticals, Inc. Business Overview Table 87. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 89. Kolltan Pharmaceuticals, Inc. Recent Development Table 90. Immunicum AB Company Information Table 91. Immunicum AB Business Overview Table 92. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 94. Immunicum AB Recent Development Table 95. Horizon Pharma Plc Company Information Table 96. Horizon Pharma Plc Business Overview Table 97. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 99. Horizon Pharma Plc Recent Development Table 100. F. Hoffmann-La Roche Ltd. Company Information Table 101. F. Hoffmann-La Roche Ltd. Business Overview Table 102. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 104. F. Hoffmann-La Roche Ltd. Recent Development Table 105. Deciphera Pharmaceuticals, LLC Company Information Table 106. Deciphera Pharmaceuticals, LLC Business Overview Table 107. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 109. Deciphera Pharmaceuticals, LLC Recent Development Table 110. Chipscreen Biosciences Ltd Company Information Table 111. Chipscreen Biosciences Ltd Business Overview Table 112. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 114. Chipscreen Biosciences Ltd Recent Development Table 115. Calithera Biosciences, Inc. Company Information Table 116. Calithera Biosciences, Inc. Business Overview Table 117. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 119. Calithera Biosciences, Inc. Recent Development Table 120. Boston Biomedical, Inc. Company Information Table 121. Boston Biomedical, Inc. Business Overview Table 122. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 124. Boston Biomedical, Inc. Recent Development Table 125. Blueprint Medicines Corporation Company Information Table 126. Blueprint Medicines Corporation Business Overview Table 127. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 129. Blueprint Medicines Corporation Recent Development Table 130. Astex Pharmaceuticals, Inc. Company Information Table 131. Astex Pharmaceuticals, Inc. Business Overview Table 132. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 134. Astex Pharmaceuticals, Inc. Recent Development Table 135. Array BioPharma Inc. Company Information Table 136. Array BioPharma Inc. Business Overview Table 137. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 138. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 139. Array BioPharma Inc. Recent Development Table 140. Arog Pharmaceuticals, Inc. Company Information Table 141. Arog Pharmaceuticals, Inc. Business Overview Table 142. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 143. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 144. Arog Pharmaceuticals, Inc. Recent Development Table 145. Ariad Pharmaceuticals, Inc. Company Information Table 146. Ariad Pharmaceuticals, Inc. Business Overview Table 147. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 148. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 149. Ariad Pharmaceuticals, Inc. Recent Development Table 150. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021-2026) & (US$ Million) Table 151. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2027-2032) & (US$ Million) Table 152. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (k units) Table 153. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2027-2032) & (k units) Table 154. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Type (2021-2026) & (US$/unit) Table 155. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Type (2027-2032) & (US$/unit) Table 156. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021-2026) & (US$ Million) Table 157. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2027-2032) & (US$ Million) Table 158. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (k units) Table 159. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2027-2032) & (k units) Table 160. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Application (2021-2026) & (US$/unit) Table 161. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Application (2027-2032) & (US$/unit) Table 162. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 166. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026) & (k units) Table 167. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2027-2032) & (k units) Table 168. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Country (2021-2026) & (US$/unit) Table 169. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Country (2027-2032) & (US$/unit) Table 170. United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 171. Canada Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 172. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 173. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021-2026) & (US$ Million) Table 174. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2027-2032) & (US$ Million) Table 175. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (k units) Table 176. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2027-2032) & (k units) Table 177. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Type (2021-2026) & (US$/unit) Table 178. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Type (2027-2032) & (US$/unit) Table 179. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021-2026) & (US$ Million) Table 180. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2027-2032) & (US$ Million) Table 181. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (k units) Table 182. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2027-2032) & (k units) Table 183. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Application (2021-2026) & (US$/unit) Table 184. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Application (2027-2032) & (US$/unit) Table 185. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 189. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026) & (k units) Table 190. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2027-2032) & (k units) Table 191. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Country (2021-2026) & (US$/unit) Table 192. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Country (2027-2032) & (US$/unit) Table 193. Germany Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 194. France Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 195. U.K. Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 196. Italy Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 197. Russia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 198. Spain Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 199. Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 200. Switzerland Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 201. Sweden Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 202. Poland Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 203. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021-2026) & (US$ Million) Table 204. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2027-2032) & (US$ Million) Table 205. China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (k units) Table 206. China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2027-2032) & (k units) Table 207. China Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Type (2021-2026) & (US$/unit) Table 208. China Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Type (2027-2032) & (US$/unit) Table 209. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021-2026) & (US$ Million) Table 210. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2027-2032) & (US$ Million) Table 211. China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (k units) Table 212. China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2027-2032) & (k units) Table 213. China Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Application (2021-2026) & (US$/unit) Table 214. China Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Application (2027-2032) & (US$/unit) Table 215. Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021-2026) & (US$ Million) Table 216. Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2027-2032) & (US$ Million) Table 217. Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (k units) Table 218. Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2027-2032) & (k units) Table 219. Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Type (2021-2026) & (US$/unit) Table 220. Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Type (2027-2032) & (US$/unit) Table 221. Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021-2026) & (US$ Million) Table 222. Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2027-2032) & (US$ Million) Table 223. Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (k units) Table 224. Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2027-2032) & (k units) Table 225. Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Application (2021-2026) & (US$/unit) Table 226. Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Application (2027-2032) & (US$/unit) Table 227. Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 228. Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 229. Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 230. Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 231. Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026) & (k units) Table 232. Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2027-2032) & (k units) Table 233. Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Country (2021-2026) & (US$/unit) Table 234. Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Country (2027-2032) & (US$/unit) Table 235. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 236. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 237. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 238. Australia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 239. Taiwan Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 240. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 241. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021-2026) & (US$ Million) Table 242. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2027-2032) & (US$ Million) Table 243. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (k units) Table 244. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2027-2032) & (k units) Table 245. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Type (2021-2026) & (US$/unit) Table 246. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Type (2027-2032) & (US$/unit) Table 247. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021-2026) & (US$ Million) Table 248. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2027-2032) & (US$ Million) Table 249. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (k units) Table 250. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2027-2032) & (k units) Table 251. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Application (2021-2026) & (US$/unit) Table 252. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Application (2027-2032) & (US$/unit) Table 253. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 254. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 255. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 256. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 257. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026) & (k units) Table 258. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2027-2032) & (k units) Table 259. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Country (2021-2026) & (US$/unit) Table 260. SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Country (2027-2032) & (US$/unit) Table 261. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 262. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 263. Chile Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 264. Colombia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 265. Peru Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 266. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 267. Israel Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 268. UAE Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 269. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 270. Iran Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 271. Egypt Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Table 272. Key Raw Materials Table 273. Raw Materials Key Suppliers Table 274. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List Table 275. Gastrointestinal Stromal Tumor (GIST) Drug Customers List Table 276. Research Programs/Design for This Report Table 277. Authors List of This Report Table 278. Secondary Sources Table 279. Primary Sources List of Figures Figure 1. Gastrointestinal Stromal Tumor (GIST) Drug Image Figure 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Amcasertib Image Figure 5. Anagrelide hydrochloride CR Image Figure 6. APG-1351 Image Figure 7. Binimetinib Image Figure 8. Others Image Figure 9. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Share 2021 VS 2025 VS 2032 Figure 11. Clinic Image Figure 12. Hospital Image Figure 13. Others Image Figure 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2032) & (US$ Million) Figure 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2021-2032) Figure 19. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (2021-2032) & (k units) Figure 20. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Gastrointestinal Stromal Tumor (GIST) Drug Sales YoY (2021-2032) & (k units) Figure 23. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales YoY (2021-2032) & (k units) Figure 24. China Gastrointestinal Stromal Tumor (GIST) Drug Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Gastrointestinal Stromal Tumor (GIST) Drug Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales YoY (2021-2032) & (k units) Figure 27. Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2021-2032) Figure 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2021-2032) Figure 36. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2021-2032) Figure 39. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2021-2032) Figure 42. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Type (2021-2032) Figure 43. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Type (2021-2032) Figure 44. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Application (2021-2032) Figure 45. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Application (2021-2032) Figure 46. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Country (2021-2032) Figure 47. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Country (2021-2032) Fi

Scope & coverage.

Types
  • Amcasertib
  • Anagrelide hydrochloride CR
  • APG-1351
  • Binimetinib
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Novartis AG
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Omeros Corporation
  • Nerviano Medical Sciences S.r.l.
  • Natco Pharma Limited
  • Kolltan Pharmaceuticals, Inc.
  • Immunicum AB
  • Horizon Pharma Plc
  • F. Hoffmann-La Roche Ltd.
  • Deciphera Pharmaceuticals, LLC
  • Chipscreen Biosciences Ltd
  • Calithera Biosciences, Inc.
  • Boston Biomedical, Inc.
  • Blueprint Medicines Corporation
  • Astex Pharmaceuticals, Inc.
  • Array BioPharma Inc.
  • Arog Pharmaceuticals, Inc.
  • Ariad Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gastrointestinal Stromal Tumor (GIST) Drug Market by Type
  3. 1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Amcasertib
  5. 1.2.3 Anagrelide hydrochloride CR
  6. 1.2.4 APG-1351
  7. 1.2.5 Binimetinib
  8. 1.2.6 Others
  9. 1.3 Gastrointestinal Stromal Tumor (GIST) Drug Market by Application
  10. 1.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Clinic
  12. 1.3.3 Hospital
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Gastrointestinal Stromal Tumor (GIST) Drug Market Dynamics
  1. 2.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Trends
  2. 2.2 Gastrointestinal Stromal Tumor (GIST) Drug Industry Drivers
  3. 2.3 Gastrointestinal Stromal Tumor (GIST) Drug Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal Stromal Tumor (GIST) Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region
  3. 3.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region
  9. 3.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturers
  2. 4.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturers
  6. 4.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers, Product Type & Application
  13. 4.7 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market CR5 and HHI
  16. 4.8.2 2025 Gastrointestinal Stromal Tumor (GIST) Drug Tier 1, Tier 2, and Tier 3
5 Gastrointestinal Stromal Tumor (GIST) Drug Market by Type
  1. 5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type
  2. 5.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type
  6. 5.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type
6 Gastrointestinal Stromal Tumor (GIST) Drug Market by Application
  1. 6.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application
  2. 6.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application
  6. 6.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application
7 Company Profiles
  1. 7.1 Novartis AG
  2. 7.1.1 Novartis AG Company Information
  3. 7.1.2 Novartis AG Business Overview
  4. 7.1.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  6. 7.1.5 Novartis AG Recent Developments
  7. 7.2 Jiangsu Hengrui Medicine Co., Ltd.
  8. 7.2.1 Jiangsu Hengrui Medicine Co., Ltd. Company Information
  9. 7.2.2 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
  10. 7.2.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  12. 7.2.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
  13. 7.3 Omeros Corporation
  14. 7.3.1 Omeros Corporation Company Information
  15. 7.3.2 Omeros Corporation Business Overview
  16. 7.3.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  18. 7.3.5 Omeros Corporation Recent Developments
  19. 7.4 Nerviano Medical Sciences S.r.l.
  20. 7.4.1 Nerviano Medical Sciences S.r.l. Company Information
  21. 7.4.2 Nerviano Medical Sciences S.r.l. Business Overview
  22. 7.4.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  24. 7.4.5 Nerviano Medical Sciences S.r.l. Recent Developments
  25. 7.5 Natco Pharma Limited
  26. 7.5.1 Natco Pharma Limited Company Information
  27. 7.5.2 Natco Pharma Limited Business Overview
  28. 7.5.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  30. 7.5.5 Natco Pharma Limited Recent Developments
  31. 7.6 Kolltan Pharmaceuticals, Inc.
  32. 7.6.1 Kolltan Pharmaceuticals, Inc. Company Information
  33. 7.6.2 Kolltan Pharmaceuticals, Inc. Business Overview
  34. 7.6.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  36. 7.6.5 Kolltan Pharmaceuticals, Inc. Recent Developments
  37. 7.7 Immunicum AB
  38. 7.7.1 Immunicum AB Company Information
  39. 7.7.2 Immunicum AB Business Overview
  40. 7.7.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  42. 7.7.5 Immunicum AB Recent Developments
  43. 7.8 Horizon Pharma Plc
  44. 7.8.1 Horizon Pharma Plc Company Information
  45. 7.8.2 Horizon Pharma Plc Business Overview
  46. 7.8.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  48. 7.8.5 Horizon Pharma Plc Recent Developments
  49. 7.9 F. Hoffmann-La Roche Ltd.
  50. 7.9.1 F. Hoffmann-La Roche Ltd. Company Information
  51. 7.9.2 F. Hoffmann-La Roche Ltd. Business Overview
  52. 7.9.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  54. 7.9.5 F. Hoffmann-La Roche Ltd. Recent Developments
  55. 7.10 Deciphera Pharmaceuticals, LLC
  56. 7.10.1 Deciphera Pharmaceuticals, LLC Company Information
  57. 7.10.2 Deciphera Pharmaceuticals, LLC Business Overview
  58. 7.10.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  60. 7.10.5 Deciphera Pharmaceuticals, LLC Recent Developments
  61. 7.11 Chipscreen Biosciences Ltd
  62. 7.11.1 Chipscreen Biosciences Ltd Company Information
  63. 7.11.2 Chipscreen Biosciences Ltd Business Overview
  64. 7.11.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  66. 7.11.5 Chipscreen Biosciences Ltd Recent Developments
  67. 7.12 Calithera Biosciences, Inc.
  68. 7.12.1 Calithera Biosciences, Inc. Company Information
  69. 7.12.2 Calithera Biosciences, Inc. Business Overview
  70. 7.12.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  72. 7.12.5 Calithera Biosciences, Inc. Recent Developments
  73. 7.13 Boston Biomedical, Inc.
  74. 7.13.1 Boston Biomedical, Inc. Company Information
  75. 7.13.2 Boston Biomedical, Inc. Business Overview
  76. 7.13.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  78. 7.13.5 Boston Biomedical, Inc. Recent Developments
  79. 7.14 Blueprint Medicines Corporation
  80. 7.14.1 Blueprint Medicines Corporation Company Information
  81. 7.14.2 Blueprint Medicines Corporation Business Overview
  82. 7.14.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  84. 7.14.5 Blueprint Medicines Corporation Recent Developments
  85. 7.15 Astex Pharmaceuticals, Inc.
  86. 7.15.1 Astex Pharmaceuticals, Inc. Company Information
  87. 7.15.2 Astex Pharmaceuticals, Inc. Business Overview
  88. 7.15.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  90. 7.15.5 Astex Pharmaceuticals, Inc. Recent Developments
  91. 7.16 Array BioPharma Inc.
  92. 7.16.1 Array BioPharma Inc. Company Information
  93. 7.16.2 Array BioPharma Inc. Business Overview
  94. 7.16.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  96. 7.16.5 Array BioPharma Inc. Recent Developments
  97. 7.17 Arog Pharmaceuticals, Inc.
  98. 7.17.1 Arog Pharmaceuticals, Inc. Company Information
  99. 7.17.2 Arog Pharmaceuticals, Inc. Business Overview
  100. 7.17.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  102. 7.17.5 Arog Pharmaceuticals, Inc. Recent Developments
  103. 7.18 Ariad Pharmaceuticals, Inc.
  104. 7.18.1 Ariad Pharmaceuticals, Inc. Company Information
  105. 7.18.2 Ariad Pharmaceuticals, Inc. Business Overview
  106. 7.18.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  108. 7.18.5 Ariad Pharmaceuticals, Inc. Recent Developments
8 North America
  1. 8.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
  2. 8.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2021-2032)
  5. 8.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
  6. 8.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2021-2032)
  9. 8.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
  10. 8.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
  2. 9.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2021-2032)
  5. 9.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
  6. 9.2.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2021-2032)
  9. 9.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
  10. 9.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
  2. 10.1.1 China Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2032)
  4. 10.1.3 China Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2021-2032)
  5. 10.2 China Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
  6. 10.2.1 China Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2032)
  8. 10.2.3 China Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
  2. 11.1.1 Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2021-2032)
  5. 11.2 Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
  6. 11.2.1 Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2021-2032)
  9. 11.3 Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
  10. 11.3.1 Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gastrointestinal Stromal Tumor (GIST) Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
  2. 12.1.1 SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
  6. 12.2.1 SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
  10. 12.3.1 SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gastrointestinal Stromal Tumor (GIST) Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gastrointestinal Stromal Tumor (GIST) Drug Value Chain Analysis
  2. 13.1.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gastrointestinal Stromal Tumor (GIST) Drug Production Mode & Process
  6. 13.2 Gastrointestinal Stromal Tumor (GIST) Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors
  9. 13.2.3 Gastrointestinal Stromal Tumor (GIST) Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst